Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT03569241

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

PEACE V: a Randomized Phase II Trial for the Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

Sponsor: University Hospital, Geneva

Conditions Metastatic Cancer Oligometastatic Cancer Prostate Cancer Prostate Cancer Metastatic

Interventions androgen deprivation therapy metastasis-directed treatment salvage Lymph Node Dissection whole pelvic radiotherapy

Updated 15 times since 2018 Last updated: Dec 4, 2024 Started: Apr 27, 2018 Primary completion: Apr 30, 2023 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Metastatic Cancer and Oligometastatic Cancer and is currently ongoing. University Hospital, Geneva leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

15 versions recorded

Sep 2025 — Present [monthly]

Active Not Recruiting PHASE2
Jan 2025 — Sep 2025 [monthly]

Active Not Recruiting PHASE2
Sep 2024 — Jan 2025 [monthly]

Active Not Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE2
Jul 2024 — Aug 2024 [monthly]

Active Not Recruiting PHASE2

▶ Show 10 earlier versions

Jul 2023 — Jul 2024 [monthly]

Active Not Recruiting PHASE2
Jan 2023 — Jul 2023 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Jan 2021 — Jan 2023 [monthly]

Recruiting PHASE2
Dec 2020 — Jan 2021 [monthly]

Recruiting PHASE2
Aug 2019 — Dec 2020 [monthly]

Recruiting PHASE2
May 2019 — Aug 2019 [monthly]

Recruiting PHASE2
Jan 2019 — May 2019 [monthly]

Recruiting PHASE2
Nov 2018 — Jan 2019 [monthly]

Recruiting PHASE2
Aug 2018 — Nov 2018 [monthly]

Recruiting PHASE2
Jul 2018 — Aug 2018 [monthly]

Recruiting PHASE2

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Geneva
University Hospital, Ghent

Data source: University Hospital, Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Antwerp, Belgium , Barakaldo, Spain , Basel, Switzerland , Bern, Switzerland , Bilbao, Spain , Bruges, Belgium , Brussels, Belgium , Geneva, Switzerland , Ghent, Belgium , Kortrijk, Belgium and 14 more locations